Published in Gut on May 01, 1994
Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer (2003) 1.25
MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
Cancer in Crohn's disease: dispelling the myths. Gut (1994) 0.95
Techniques for targeting screening in ulcerative colitis. Postgrad Med J (2007) 0.86
Magnifying chromoscopy, a novel and useful technique for colonoscopy in ulcerative colitis. World J Gastroenterol (2007) 0.81
Dysplasia in ulcerative colitis--clinical consequences? Langenbecks Arch Surg (2004) 0.81
Simultaneous detection of synchronous colonic and biliary carcinoma by abdominal ultrasonography in two patients with ulcerative colitis. Dig Dis Sci (2005) 0.78
Cancer surveillance in ulcerative colitis. Gut (1995) 0.75
Inflammatory Bowel Disease Associated Colorectal Neoplasia. J Gastrointest Dig Syst (2012) 0.75
Ulcerative colitis: the fate of the retained rectum. Clin Colon Rectal Surg (2004) 0.75
Clinical gastroenterology. BMJ (1995) 0.75
THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. Gut (1964) 8.63
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut (1967) 7.39
Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet (1989) 4.72
Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J (1966) 4.27
The development of carcinoma of the large intestine in ulcerative colitis. Br J Surg (1959) 3.67
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med (1971) 3.10
Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology (1992) 2.86
Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology (1981) 2.75
Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen. Gut (1985) 2.72
Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet (1983) 2.67
Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med (1987) 2.61
Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology (1992) 2.51
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology (1992) 2.48
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
Cancer risk in extensive ulcerative colitis. Ann Surg (1978) 2.40
Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut (1990) 1.99
Cancer surveillance in ulcerative colitis. Gastroenterology (1991) 1.93
Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Gut (1986) 1.87
Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology (1991) 1.86
Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82
Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology (1988) 1.81
Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology (1985) 1.66
Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology (1980) 1.50
On calculating cancer risk and survival of ulcerative colitis patients with the life table method. Gastroenterology (1976) 1.44
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Surveillance in ulcerative colitis: burdens and benefit. Gut (1988) 1.40
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci (1989) 1.34
Colon cancer in ulcerative colitis. Gastroenterology (1988) 1.26
Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut (1990) 1.24
Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol (1988) 1.24
Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut (1991) 1.16
Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology (1988) 1.16
Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol (1980) 1.11
Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut (1987) 1.06
Rectal biopsy and precancer in ulcerative colitis. Gut (1974) 0.98
Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass. Gut (1989) 0.92
Colonoscopic surveillance for cancer in patients with chronic ulcerative colitis: is it working? Gastroenterology (1991) 0.78